Advances in lung cancer treatment using nanomedicines

A Sharma, D Shambhwani, S Pandey, J Singh… - ACS …, 2022 - ACS Publications
Carcinoma of the lungs is among the most menacing forms of malignancy and has a poor
prognosis, with a low overall survival rate due to delayed detection and ineffectiveness of …

Chitosan-based hydrogels: Preparation, properties and applications

Z Shariatinia, AM Jalali - International journal of biological macromolecules, 2018 - Elsevier
Chitosan (CS), the second most plentiful natural polysaccharide next to cellulose, has
valuable characteristics including biocompatibility, nontoxicity and biodegradability. CS is …

Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery

Q Liu, J Guan, L Qin, X Zhang, S Mao - Drug discovery today, 2020 - Elsevier
Highlights•Clearance routes of nanoparticles in the lung are presented.•Factors influencing
nanoparticle transaction are discussed.•Physicochemical properties of the nanoparticles …

[HTML][HTML] Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines

Y Guo, H Bera, C Shi, L Zhang, D Cun… - Acta Pharmaceutica Sinica …, 2021 - Elsevier
Pulmonary administration route has been extensively exploited for the treatment of local
lung diseases such as asthma, chronic obstructive pulmonary diseases and respiratory …

[HTML][HTML] Oral inhalation for delivery of proteins and peptides to the lungs

E Fröhlich, S Salar-Behzadi - European Journal of Pharmaceutics and …, 2021 - Elsevier
Oral inhalation is the preferred route for delivery of small molecules to the lungs, because
high tissue levels can be achieved shortly after application. Biologics are mainly …

Chitosan: A versatile bio-platform for breast cancer theranostics

VS Madamsetty, S Tavakol, S Moghassemi… - Journal of Controlled …, 2022 - Elsevier
Breast cancer is considered one of the utmost neoplastic diseases globally, with a high
death rate of patients. Over the last decades, many approaches have been studied to early …

Polymer-drug conjugates: Design principles, emerging synthetic strategies and clinical overview

A Javia, J Vanza, D Bardoliwala, S Ghosh… - International Journal of …, 2022 - Elsevier
Adagen, an enzyme replacement treatment for adenosine deaminase deficiency, was the
first protein-polymer conjugate to be approved in early 1990 s. Post this regulatory approval …

Combination therapy strategies for the treatment of malaria

S Alven, B Aderibigbe - Molecules, 2019 - mdpi.com
Malaria is a vector-and blood-borne infection that is responsible for a large number of
deaths around the world. Most of the currently used antimalarial therapeutics suffer from …

Challenges and strategies in drug delivery systems for treatment of pulmonary infections

DK Ho, BLB Nichols, KJ Edgar, X Murgia… - European journal of …, 2019 - Elsevier
Inhalation therapy has been reported as the most effective treatment for respiratory bacterial
infections due to the increasing relevance of drug bioavailability. Drug delivery systems …

Polymer-drug conjugate, a potential therapeutic to combat breast and lung cancer

S Alven, X Nqoro, B Buyana, BA Aderibigbe - Pharmaceutics, 2020 - mdpi.com
Cancer is a chronic disease that is responsible for the high death rate, globally. The
administration of anticancer drugs is one crucial approach that is employed for the treatment …